mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.00087 |
1 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.00087 |
1 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.0011 |
1 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.00081 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0007 |
1 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.00056 |
1 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.0006 |
1 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.0006 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00058 |
1 |